Mimedx (MDXG) Goodwill & Intangibles (2010 - 2026)
Mimedx (MDXG) reported Goodwill & Intangibles of $32.6 million for Q1 2026, up 6.81% on a YoY basis from $30.5 million in Q1 2025, and down 3.03% sequentially from $33.6 million in Q4 2025.
Mimedx (MDXG) Goodwill & Intangibles (2010 - 2026) Analysis & Trends
Mimedx (MDXG) has 17 years of Goodwill & Intangibles data on file, last reported at $32.6 million in Q1 2026.
- For the quarter ending Q1 2026, Goodwill & Intangibles rose 6.81% year-over-year to $32.6 million; the trailing twelve-month figure through Mar 2026 stood at $32.6 million (up 6.81% YoY), and the FY2025 full-year result was $33.6 million, up 8.15% from the prior year.
- Goodwill & Intangibles slipped to $32.6 million in Q1 2026, from $33.6 million in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $33.6 million in Q4 2025 to a low of $5.0 million in Q3 2022.
- A 5-year average of $26.2 million and a median of $30.5 million in 2025 frame the typical range for Goodwill & Intangibles.
- Across the five-year window, Goodwill & Intangibles sank 80.5% in 2022 and soared 397.52% in 2023, its largest moves.
- Tracing MDXG's Goodwill & Intangibles over 5 years: stood at $25.3 million in 2022, then decreased by 2.35% to $24.7 million in 2023, then gained by 25.79% to $31.1 million in 2024, then increased by 8.15% to $33.6 million in 2025, then dropped by 3.03% to $32.6 million in 2026.
- Business Quant data shows MDXG's Goodwill & Intangibles at $32.6 million in Q1 2026, $33.6 million in Q4 2025, and $30.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,440.76 Bn | 66,440.47 Bn | - |
| 2 | Nanobiotix | 1,880.51 Bn | 1,880.45 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 467.94 Bn | 463.15 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.63 Bn | 115.38 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.30 Bn | 61.54 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.81 Bn | 62.81 Bn | - |
| 8 | Argenx Se | 55.78 Bn | 50.59 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.33 Bn | 34.32 Bn | 959.66 Mn |
| 10 | Mimedx | 639.06 Mn | 479.29 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.58 Mn |
| Dec 31, 2025 | 33.60 Mn |
| Sep 30, 2025 | 30.59 Mn |
| Jun 30, 2025 | 31.47 Mn |
| Mar 31, 2025 | 30.50 Mn |
| Dec 31, 2024 | 31.07 Mn |
| Sep 30, 2024 | 30.64 Mn |
| Jun 30, 2024 | 31.49 Mn |
| Mar 31, 2024 | 31.99 Mn |
| Dec 31, 2023 | 24.70 Mn |
| Sep 30, 2023 | 24.84 Mn |
| Jun 30, 2023 | 25.01 Mn |
| Mar 31, 2023 | 25.68 Mn |
| Dec 31, 2022 | 25.29 Mn |
| Sep 30, 2022 | 4.99 Mn |
| Jun 30, 2022 | 5.14 Mn |
| Mar 31, 2022 | 25.24 Mn |
| Dec 31, 2021 | 24.82 Mn |
| Sep 30, 2021 | 25.60 Mn |
| Jun 30, 2021 | 25.73 Mn |